Busulfex 01
Busulfex Injection
Product Images NDC 59148-070
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Busulfex (NDC 59148-070). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Otsuka America Pharmaceutical, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Busulfex 02
This is a description of a medication contained in a 10 mL single-dose vial. The vial contains 60 mg of busulfan USP, 3.3 mL of dimethylacetamide, and 6.7 mL of polyethylene glycol-400, NF. It is cautioned that the medication must be diluted before use, and any unused portion should be discarded. The medication is intended for intravenous infusion only, and information regarding dosage and administration can be found in the package insert. The medication should be stored refrigerated between 2°C and 8°C (36°F to 46°F). The medication is distributed and marketed by Otsuka America Pharmaceutical, Inc.*
Busulfex 03
This is a description of a medication called Busulfan, in the form of a 10 mL vial intended for intravenous infusion only. The NDC code is 531481. The package insert contains information about dosage and administration. The vial contains 60 mg of busulfan USP, 2 sl 33 ml dimethylacetamide, and 6.7 mL polyethylene glycol-400, NF. Any unused portion should be discarded. The medication is manufactured by Bater Oncology GmbH in Germany and should be stored refrigerated at between 2°C to 8°C (36°F to 46°F).*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
